Sponsor: Zai Lab (Shanghai) Co., Ltd.
Protocol ZL-1201-001. First in Human, Phase I Trial of Anti-CD47 Antibody ZL-1201 in Subjects with Advanced Cancer. A study for patients with previously treated advanced or metastatic solid tumors or lymphoma.
For more information please contact the clinical research department: 631-675-5075